Inventor
LI ZHENWU
US17 patents
⚠️ This page may combine multiple inventors who share the name “LI ZHENWU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
12 patentsUS11407749B2Aug 9, 2022
Heterocyclic compounds as immunomodulators
INCYTE CORP23 citations94
US9944647B2Apr 17, 2018
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP30 citations94
US11608337B2Mar 21, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP15 citations86
US11596692B1Mar 7, 2023
PD-L1/STING conjugates and methods of use
INCYTE CORP12 citations86
US10800779B2Oct 13, 2020
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP6 citations84
US11851426B2Dec 26, 2023
Bicyclic amines as CDK2 inhibitors
INCYTE CORP3 citations72
US11713317B2Aug 1, 2023
Tricyclic heterocyclic compounds as sting activators
INCYTE CORP3 citations72
US11472791B2Oct 18, 2022
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
INCYTE CORP7 citations72
US10947227B2Mar 16, 2021
Tricyclic heterocyclic compounds as sting activators
INCYTE CORP5 citations72
US11401272B2Aug 2, 2022
Heterocyclic compounds as LSD1 inhibitors
INCYTE CORP0 citations62
US12466828B2Nov 11, 2025
Bicyclic amines as CDK2 inhibitors
INCYTE CORP0 citations60
US12466822B2Nov 11, 2025
Heterocyclic compounds as immunomodulators
INCYTE CORP0 citations51